当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析 - 现金流量表

我武生物

(300357)

  

流通市值:152.29亿  总市值:164.72亿
流通股本:4.84亿   总股本:5.24亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金516,650,905.38253,680,603.8890,740,667.96622,952,412.46
  收到的税费返还--13,716-
  收到其他与经营活动有关的现金12,510,748.277,966,416.8323,776,899.0920,056,582.89
  经营活动现金流入小计529,161,653.65261,647,020.63914,531,283.05643,008,995.35
  购买商品、接受劳务支付的现金16,271,293.878,840,894.8228,308,352.8720,721,902.07
  支付给职工以及为职工支付的现金142,754,196.2672,812,019.48283,537,448.19209,283,985.99
  支付的各项税费48,447,199.2324,605,269.0698,353,193.4466,424,112.44
  支付其他与经营活动有关的现金121,173,112.1969,505,168.62241,892,283.33186,405,618.86
  经营活动现金流出小计328,645,801.55175,763,351.98652,091,277.83482,835,619.36
  经营活动产生的现金流量净额200,515,852.185,883,668.65262,440,005.22160,173,375.99
二、投资活动产生的现金流量:
  收回投资收到的现金451,567,200351,000,000204,000,000163,000,000
  取得投资收益收到的现金1,465,742.81992,400.122,905,526.682,501,695.19
  处置固定资产、无形资产和其他长期资产收回的现金净额--15,00015,000
  收到的其他与投资活动有关的现金--9,638,557.178,589,720.57
  投资活动现金流入小计453,032,942.81351,992,400.12216,559,083.85174,106,415.76
  购建固定资产、无形资产和其他长期资产支付的现金88,217,827.0245,487,365.26117,970,037.9198,070,665.64
  投资支付的现金489,760,000285,760,000682,838,000611,500,000
  支付其他与投资活动有关的现金9,155,282.028,159,851.3211,346,201.59,100,201.5
  投资活动现金流出小计587,133,109.04339,407,216.58812,154,239.41718,670,867.14
  投资活动产生的现金流量净额-134,100,166.2312,585,183.54-595,595,155.56-544,564,451.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金--13,077-
  其中:子公司吸收少数股东投资收到的现金--13,077-
  取得借款收到的现金15,000,00015,000,0002,762,114.332,762,114.33
  筹资活动现金流入小计15,000,00015,000,0002,775,191.332,762,114.33
  偿还债务支付的现金22,577,392.7122,577,392.7144,121,654.3919,535,029.63
  分配股利、利润或偿付利息支付的现金52,430,858.3452,430,858.3497,447,671.3397,447,671.33
  支付其他与筹资活动有关的现金3,474,035.31,458,104.677,785,789.076,116,316.07
  筹资活动现金流出小计78,482,286.3576,466,355.72149,355,114.79123,099,017.03
  筹资活动产生的现金流量净额-63,482,286.35-61,466,355.72-146,579,923.46-120,336,902.7
四、汇率变动对现金及现金等价物的影响-4,641.7-1,126.247,802.61-2,298.95
五、现金及现金等价物净增加额2,928,757.8237,001,370.23-479,727,271.19-504,730,277.04
  加:期初现金及现金等价物余额97,862,286.8197,862,286.81577,589,558577,589,558
  期末现金及现金等价物余额100,791,044.63134,863,657.0497,862,286.8172,859,280.96
补充资料:
  净利润170,429,226.33-304,338,394.93-
  资产减值准备2,207,917.71-958,291.22-
  固定资产和投资性房地产折旧16,183,925.54-30,976,028.13-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧16,183,925.54-30,976,028.13-
  无形资产摊销6,725,077.34-12,609,822.6-
  长期待摊费用摊销1,208,203.77-2,279,811.63-
  处置固定资产、无形资产和其他长期资产的损失-630,073.33--568,926.85-
  固定资产报废损失320,072.27-1,415,047.93-
  公允价值变动损失-1,328,169.78--2,429,584.92-
  财务费用406,344.87-1,062,798.45-
  投资损失-16,143.8--4,040,186.3-
  递延所得税-480,927.78--597,032.92-
  其中:递延所得税资产减少-452,417.26--566,501.11-
    递延所得税负债增加-28,510.52--30,531.81-
  存货的减少1,380,977.75-1,304,079.78-
  经营性应收项目的减少10,543,053.48--99,787,232.1-
  经营性应付项目的增加-9,356,634.69-7,691,367.51-
  现金的期末余额100,791,044.63-97,862,286.81-
  减:现金的期初余额97,862,286.81-577,589,558-
  现金及现金等价物的净增加额2,928,757.82--479,727,271.19-
公告日期2025-08-222025-04-192025-04-192024-10-24
审计意见(境内)标准无保留意见
TOP↑